The “Code Drugs in Cardiac Arrest”—the use of cardioactive medications in cardiac arrest resuscitation

      Abstract

      In October of 2010, the American Heart Association (AHA) published the 2010 Guidelines on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. These guidelines place significant emphasis on 5 major areas of therapy in patient with cardiac arrest, including immediate recognition and activation of the emergency response team, effective chest compressions, rapid defibrillation, effective advanced life support (ALS), and integrated postresuscitation care. “Effective ALS” includes the placement of an advanced airway, establishment of parenteral access, and the administration of cardioactive medications. Advanced life support encompasses only 1 of these 5 major areas of cardiac arrest intervention—in sharp contrast to past renditions of the AHA guidelines in which ALS was significantly emphasized. In fact, recent research and the AHA guidelines note that ALS therapy is less important than previously thought. This article will briefly review the evidence regarding the use of the 5 principal medications—epinephrine, vasopressin, atropine, lidocaine, and amiodarone—used in Advanced Cardiac Life Support cardiac arrest algorithm.
      To read this article in full you will need to make a payment

      References

        • Field J.M.
        • Hazinski M.F.
        • Sayre M.R.
        • et al.
        Part 1: Executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
        Circulation. 2010; 122: S640-S656
        • Morrison L.J.
        • Deakin C.D.
        • Morley P.T.
        • et al.
        Part 8: Advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.
        Circulation. 2010; 122: S345-S421
        • Nolan J.P.
        • Soar J.
        • Zideman D.A.
        • et al.
        European Resuscitation Council Guidelines for Resuscitation 2010: Section 1. Executive Summary.
        Resuscitation. 2010;
        • Mitchell R.G.
        • Brady W.
        • Guly U.M.
        • et al.
        Comparison of two emergency response systems and their effect on survival from out of hospital cardiac arrest.
        Resuscitation. 1997; 35: 225-229
        • Hermreck A.S.
        The history of cardiopulmonary resuscitation.
        Am J Surg. 1988; 156: 430-436
        • Gottlieb R.
        Ueber die wirkung der nebennierenextracte auf herz und blutdruck.
        Arch Exp Pathol Pharm Leipzig. 1896; 38: 99-112
        • Crile G.
        • Dolley D.H.
        An experimental research into the resuscitation of dogs killed by anesthetics and asphyxia.
        J Exp Med. 1906; 8: 713-725
        • Pearson J.W.
        • Redding J.S.
        Epinephrine in cardiac resuscitation.
        Am Heart J. 1963; 66: 210-214
        • Pearson J.W.
        • Redding J.S.
        The role of epinephrine in cardiac resuscitation.
        Anesth Analg. 1963; 42: 599-606
        • Pearson J.W.
        • Redding J.S.
        Cardiac arrest and adrenaline.
        Lancet. 1964; 283: 935
        • Yakaitis R.W.
        • Otto C.W.
        • Blitt C.D.
        Relative importance of alpha and beta adrenergic receptors during resuscitation.
        Crit Care Med. 1979; 7: 293-296
        • Michael J.R.
        • Guerci A.D.
        • Koehler R.C.
        • et al.
        Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs.
        Circulation. 1984; 69: 822-835
        • Brown C.G.
        • Werman H.A.
        • Davis E.A.
        • et al.
        Comparative effect of graded doses of epinephrine on regional brain blood flow during CPR in a swine model.
        Ann Emerg Med. 1986; 15: 1138-1144
        • Koehler R.C.
        • Michael J.R.
        • Guerci A.D.
        • et al.
        Beneficial effect of epinephrine infusion on cerebral and myocardial blood flows during CPR.
        Ann Emerg Med. 1985; 14: 744-749
        • Hoekstra J.W.
        • Van Ligten P.
        • Neumar R.
        • et al.
        Effect of high dose norepinephrine versus epinephrine on cerebral and myocardial blood flow during CPR.
        Resuscitation. 1990; 19: 227-240
        • Paradis N.A.
        • Martin G.B.
        • Rivers E.P.
        • et al.
        Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation.
        JAMA. 1990; 263: 1106-1113
        • Kern K.B.
        • Ewy G.A.
        • Voorhees W.D.
        • et al.
        Myocardial perfusion pressure: a predictor of 24-hour survival during prolonged cardiac arrest in dogs.
        Resuscitation. 1988; 16: 241-250
        • Lindberg L.
        • Liao Q.
        • Steen S.
        The effects of epinephrine/norepinephrine on end-tidal carbon dioxide concentration, coronary perfusion pressure and pulmonary arterial blood flow during cardiopulmonary resuscitation.
        Resuscitation. 2000; 43: 129-140
        • Thrush D.N.
        • Downs J.B.
        • Smith R.A.
        Is epinephrine contraindicated during cardiopulmonary resuscitation?.
        Circulation. 1997; 96: 2709-2714
        • Cantineau J.P.
        • Merckx P.
        • Lambert Y.
        • et al.
        Effect of epinephrine on end-tidal carbon dioxide pressure during prehospital cardiopulmonary resuscitation.
        Am J Emerg Med. 1994; 12: 267-270
        • Callaham M.
        • Barton C.
        • Matthay M.
        Effect of epinephrine on the ability of end-tidal carbon dioxide readings to predict initial resuscitation from cardiac arrest.
        Crit Care Med. 1992; 20: 337-343
        • Ditchey R.V.
        • Lindenfeld J.
        Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs.
        Circulation. 1988; 78: 382-389
        • Tang W.
        • Weil M.H.
        • Sun S.
        • et al.
        Epinephrine increases the severity of postresuscitation myocardial dysfunction.
        Circulation. 1995; 92: 3089-3093
        • Tovar O.H.
        • Jones J.L.
        Epinephrine facilitates cardiac fibrillation by shortening action potential refractoriness.
        J Mol Cell Cardiol. 1997; 29: 1447-1455
        • Neumar R.
        • Bircher N.
        • Radovsky M.
        • et al.
        Myocardial necrosis after high-dose epinephrine during CPR.
        Ann Emerg Med. 1993; 22: 892-893
        • Brillman J.
        • Sanders A.
        • Otto C.W.
        • et al.
        Comparison of epinephrine and phenylephrine for resuscitation and neurologic outcome of cardiac arrest in dogs.
        Ann Emerg Med. 1987; 16: 11-17
        • Silfvast T.
        • Saarnivaara L.
        • Kinnunen A.
        • et al.
        Comparison of adrenaline and phenylephrine in out-of-hospital cardiopulmonary resuscitation. A double-blind study.
        Acta Anaesthesiol Scand. 1985; 29: 610-613
        • Callaham M.
        • Madsen C.D.
        • Barton C.W.
        • et al.
        A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest.
        JAMA. 1992; 268: 2667-2672
        • Gueugniaud P.Y.
        • Mols P.
        • Goldstein P.
        • et al.
        A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group.
        N Engl J Med. 1998; 339: 1595-1601
        • Choux C.
        • Gueugniaud P.Y.
        • Barbieux A.
        • et al.
        Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital.
        Resuscitation. 1995; 29: 3-9
        • Stiell I.G.
        • Hebert P.C.
        • Weitzman B.N.
        • et al.
        High-dose epinephrine in adult cardiac arrest.
        N Engl J Med. 1992; 327: 1045-1050
        • Brown C.G.
        • Martin D.R.
        • Pepe P.E.
        • et al.
        A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The multicenter high-dose epinephrine study group.
        N Engl J Med. 1992; 327: 1051-1055
        • Vandycke C.
        • Martens P.
        High dose versus standard dose epinephrine in cardiac arrest—a meta-analysis.
        Resuscitation. 2000; 45: 161-166
        • Yanagawa Y.
        • Sakamoto T.
        Analysis of prehospital care for cardiac arrest in an urban setting in Japan.
        J Emerg Med. 2010; 38: 340-345
        • Herlitz J.
        • Ekstrom L.
        • Wennerblom B.
        • et al.
        Adrenaline in out-of-hospital ventricular fibrillation. Does it make any difference?.
        Resuscitation. 1995; 29: 195-201
        • Holmberg M.
        • Holmberg S.
        • Herlitz J.
        Low chance of survival among patients requiring adrenaline (epinephrine) or intubation after out-of-hospital cardiac arrest in Sweden.
        Resuscitation. 2002; 54: 37-45
        • Ong M.E.
        • Tan E.H.
        • Ng F.S.
        • et al.
        Survival outcomes with the introduction of intravenous epinephrine in the management of out-of-hospital cardiac arrest.
        Ann Emerg Med. 2007; 50: 635-642
        • Woodhouse S.P.
        • Cox S.
        • Boyd P.
        • et al.
        High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest.
        Resuscitation. 1995; 30: 243-249
        • Jacobs I.
        • Finn J.
        • Jelinek G.
        • et al.
        A randomised placebo controlled trial of adrenaline in cardiac arrest—the PACA trial.
        Resuscitation. 2010; 81: S3
        • Lindner K.H.
        • Strohmenger H.U.
        • Ensinger H.
        • et al.
        Stress hormone response during and after cardiopulmonary resuscitation.
        Anesthesiology. 1992; 77: 662-668
        • Lindner K.H.
        • Haak T.
        • Keller A.
        • et al.
        Release of endogenous vasopressors during and after cardiopulmonary resuscitation.
        Heart. 1996; 75: 145-150
        • Meybohm P.
        • Cavus E.
        • Dorges V.
        • et al.
        Revised resuscitation guidelines: adrenaline versus adrenaline/vasopressin in a pig model of cardiopulmonary resuscitation—a randomised, controlled trial.
        Resuscitation. 2007; 75: 380-388
        • Wenzel V.
        • Lindner K.H.
        • Krismer A.C.
        • et al.
        Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs.
        Circulation. 1999; 99: 1379-1384
        • Lindner K.H.
        • Brinkmann A.
        • Pfenninger E.G.
        • et al.
        Effect of vasopressin on hemodynamic variables, organ blood flow, and acid-base status in a pig model of cardiopulmonary resuscitation.
        Anesth Analg. 1993; 77: 427-435
        • Lindner K.H.
        • Prengel A.W.
        • Pfenninger E.G.
        • et al.
        Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs.
        Circulation. 1995; 91: 215-221
        • Morris D.C.
        • Dereczyk B.E.
        • Grzybowski M.
        • et al.
        Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation.
        Acad Emerg Med. 1997; 4: 878-883
        • Mally S.
        • Jelatancev A.
        • Grmec S.
        Effects of epinephrine and vasopressin on end-tidal carbon dioxide tension and mean arterial blood pressure in out-of-hospital cardiopulmonary resuscitation: an observational study.
        Crit Care. 2007; 11: R39
        • Lindner K.H.
        • Prengel A.W.
        • Brinkmann A.
        • et al.
        Vasopressin administration in refractory cardiac arrest.
        Ann Intern Med. 1996; 124: 1061-1064
        • Lindner K.H.
        • Dirks B.
        • Strohmenger H.U.
        • et al.
        Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation.
        Lancet. 1997; 349: 535-537
        • Guyette F.X.
        • Guimond G.E.
        • Hostler D.
        • et al.
        Vasopressin administered with epinephrine is associated with a return of a pulse in out-of-hospital cardiac arrest.
        Resuscitation. 2004; 63: 277-282
        • Grmec S.
        • Mally S.
        Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: an observational cohort study.
        Crit Care. 2006; 10: R13
        • Mentzelopoulos S.D.
        • Zakynthinos S.G.
        • Tzoufi M.
        • et al.
        Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest.
        Arch Intern Med. 2009; 169: 15-24
        • Mukoyama T.
        • Kinoshita K.
        • Nagao K.
        • et al.
        Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitation.
        Resuscitation. 2009; 80: 755-761
        • Callaway C.W.
        • Hostler D.
        • Doshi A.A.
        • et al.
        Usefulness of vasopressin administered with epinephrine during out-of-hospital cardiac arrest.
        Am J Cardiol. 2006; 98: 1316-1321
        • Gueugniaud P.Y.
        • David J.S.
        • Chanzy E.
        • et al.
        Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation.
        N Engl J Med. 2008; 359: 21-30
        • Stiell I.G.
        • Hebert P.C.
        • Wells G.A.
        • et al.
        Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial.
        Lancet. 2001; 358: 105-109
        • Wenzel V.
        • Krismer A.C.
        • Arntz H.R.
        • et al.
        A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation.
        N Engl J Med. 2004; 350: 105-113
        • Aung K.
        • Htay T.
        Vasopressin for cardiac arrest: a systematic review and meta-analysis.
        Arch Intern Med. 2005; 165: 17-24
        • Biondi-Zoccai G.G.
        • Abbate A.
        • Parisi Q.
        • et al.
        Is vasopressin superior to adrenaline or placebo in the management of cardiac arrest? A meta-analysis.
        Resuscitation. 2003; 59: 221-224
        • van Alem A.P.
        • Post J.
        • Koster R.W.
        VF recurrence: characteristics and patient outcome in out-of-hospital cardiac arrest.
        Resuscitation. 2003; 59: 181-188
        • von Planta M.
        • Chamberlain D.
        Drug treatment of arrhythmias during cardiopulmonary resuscitation. A statement for the advanced life support working party of the European Resuscitation Council.
        Resuscitation. 1992; 24: 227-232
        • Lie K.I.
        • Wellens H.J.
        • van Capelle F.J.
        • et al.
        Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.
        N Engl J Med. 1974; 291: 1324-1326
        • Koster R.W.
        • Dunning A.J.
        Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction.
        N Engl J Med. 1985; 313: 1105-1110
        • Berntsen R.F.
        • Rasmussen K.
        Lidocaine to prevent ventricular fibrillation in the prehospital phase of suspected acute myocardial infarction: the north-Norwegian lidocaine intervention trial.
        Am Heart J. 1992; 124: 1478-1483
        • Armengol R.E.
        • Graff J.
        • Baerman J.M.
        • et al.
        Lack of effectiveness of lidocaine for sustained, wide QRS complex tachycardia.
        Ann Emerg Med. 1989; 18: 254-257
        • Nasir Jr, N.
        • Taylor A.
        • Doyle T.K.
        • et al.
        Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction.
        Am J Cardiol. 1994; 74: 1183-1186
        • Dorian P.
        • Fain E.S.
        • Davy J.M.
        • et al.
        Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements.
        J Am Coll Cardiol. 1986; 8: 327-332
        • Ujhelyi M.R.
        • Schur M.
        • Frede T.
        • et al.
        Mechanism of antiarrhythmic drug-induced changes in defibrillation threshold: role of potassium and sodium channel conductance.
        J Am Coll Cardiol. 1996; 27: 1534-1542
        • Herlitz J.
        • Ekstrom L.
        • Wennerblom B.
        • et al.
        Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival?.
        Resuscitation. 1997; 33: 199-205
        • Harrison E.E.
        Lidocaine in prehospital countershock refractory ventricular fibrillation.
        Ann Emerg Med. 1981; 10: 420-423
        • Weaver W.D.
        • Fahrenbruch C.E.
        • Johnson D.D.
        • et al.
        Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation.
        Circulation. 1990; 82: 2027-2034
        • Williams M.L.
        • Woelfel A.
        • Cascio W.E.
        • et al.
        Intravenous amiodarone during prolonged resuscitation from cardiac arrest.
        Ann Intern Med. 1989; 110: 839-842
        • Dorian P.
        • Cass D.
        • Schwartz B.
        • et al.
        Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.
        N Engl J Med. 2002; 346: 884-890
        • Kudenchuk P.J.
        • Cobb L.A.
        • Copass M.K.
        • et al.
        Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.
        N Engl J Med. 1999; 341: 871-878
        • Brown D.C.
        • Lewis A.J.
        • Criley J.M.
        Asystole and its treatment: the possible role of the parasympathetic nervous system in cardiac arrest.
        J Am Coll Emerg Phys. 1979; 8: 448-452
        • Stueven H.A.
        • Tonsfeldt D.J.
        • Thompson B.M.
        • et al.
        Atropine in asystole: human studies.
        Ann Emerg Med. 1984; 13: 815-817
        • Coon G.A.
        • Clinton J.E.
        • Ruiz E.
        Use of atropine for brady-asystolic prehospital cardiac arrest.
        Ann Emerg Med. 1981; 10: 462-467
        • Tortolani A.J.
        • Risucci D.A.
        • Powell S.R.
        • et al.
        In-hospital cardiopulmonary resuscitation during asystole. Therapeutic factors associated with 24-hour survival.
        Chest. 1989; 96: 622-626
        • Stiell I.G.
        • Wells G.A.
        • Hebert P.C.
        • et al.
        Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs.
        Acad Emerg Med. 1995; 2: 264-273
        • van Walraven C.
        • Stiell I.G.
        • Wells G.A.
        • et al.
        Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? The OTAC study group.
        Ann Emerg Med. 1998; 32: 544-553
        • Stiell I.G.
        • Wells G.A.
        • Field B.
        • et al.
        Advanced cardiac life support in out-of-hospital cardiac arrest.
        N Engl J Med. 2004; 351: 647-656
        • Olasveengen T.M.
        • Sunde K.
        • Brunborg C.
        • et al.
        Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial.
        J Am Med Assoc. 2009; 302: 2222-2229
        • Ohshige K.
        • Shimazaki S.
        • Hirasawa H.
        • et al.
        Evaluation of out-of-hospital cardiopulmonary resuscitation with resuscitative drugs: a prospective comparative study in Japan.
        Resuscitation. 2005; 66: 53-61
        • Nichol G.
        • Stiell I.G.
        • Laupacis A.
        • et al.
        A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest.
        Ann Emerg Med. 1999; 34: 517-525
      Advertisement